Technical / White Paper

Capros® Superfruit: Next Generation Product for Cardiovascular Health

Published

Format: PDF file | Document type: Technical / White Paper

Capros® Superfruit: Next Generation Product for Cardiovascular Health

Capros​®, backed by 8 clinical studies and one mechanism of action study, is an excellent product for Heart Health. In addition, it is a super antioxidant with an ORAC value of 47,000 µmoles TE/gram. Capros® has a new patent issued on endothelial function enhancement, increased production of NO, decreased LDL and increased HDL. Two other patents cover platelet aggregation inhibition properties and pro-oxidation-free anti-oxidant properties.  Peer reviewed publications pending include Supplementation of a Standardized Extract from Phyllanthus emblica Improves Cardiovascular Risk Factors and Platelet Aggregation in Overweight Adults​” and “Protective Effects of Phyllanthus emblica derived Capros® on Myocardial Ischemia-Reperfusion Injury via Activation of the PI3-Kinase / Glycogen Synthase Kinase-3β/ β-Catenin Cardio-Protective Pathway​”.

Related resources from Natreon Inc.

Show more

Supplier info centre